Guidance for the use of thrombolytic therapy for the treatment of venous thromboembolism
- PMID: 26780739
- PMCID: PMC4715849
- DOI: 10.1007/s11239-015-1318-z
Guidance for the use of thrombolytic therapy for the treatment of venous thromboembolism
Abstract
Patients with venous thromboembolism (VTE) are prone to the development of both short-term and long-term complications that can substantially affect their functional capacity and quality of life. Patients with deep vein thrombosis (DVT) often develop recurrent VTE or the post-thrombotic syndrome, whereas patients with pulmonary embolism (PE) can develop long-term symptoms and functional limitations along a broad spectrum extending to full-blown chronic thromboembolic pulmonary hypertension. Clinicians who care for patients showing severe clinical manifestations of DVT and PE are often faced with challenging decisions concerning whether and how to escalate to more aggressive treatments such as those involving the use of thrombolytic drugs. The purpose of this chapter is to provide guidance on how best to individualize care to these patients.
Keywords: Anticoagulants; Direct oral anticoagulants (DOAC); New oral anticoagulants (NOAC); Pulmonary embolism; Thrombolytic therapy; Venous thromboembolism.
Figures
References
-
- The surgeon general’s call to action to prevent deep vein thrombosis and pulmonary embolism. U.S. Department of Health and Human Services (2008) www.Surgeongeneral.Gov/topics/deepvein/calltoaction/call-to-action-on-dv... - PubMed
-
- Casazza F, Becattini C, Bongarzoni A, Cuccia C, Roncon L, Favretto G, Zonzin P, Pignataro L, Agnelli G. Clinical features and short term outcomes of patients with acute pulmonary embolism. The italian pulmonary embolism registry (iper) Thromb Res. 2012;130:847–852. doi: 10.1016/j.thromres.2012.08.292. - DOI - PubMed
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
